# Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer

> **NCT01084083** · PHASE2 · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 90 (actual)

## Conditions studied

- Head and Neck Cancer
- Precancerous Condition

## Interventions

- **BIOLOGICAL:** cetuximab
- **RADIATION:** intensity-modulated radiation therapy (IMRT)
- **DRUG:** Paclitaxel
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT01084083
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08-11
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2023-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01084083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01084083, "Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01084083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*